A third scale—Clinician Global Impression of Change
[CGIC] adopted based on clinical examination of affected
joint/joints by an orthopedic consultant showed significant
improvement in patients treated with NR-INF-02. This
effect may be considered as an additional parameter supporting
its therapeutic efficacy. As clinical examination
plays a crucial role in evaluation of symptoms the observed
decrease in the joint tenderness and effusion in the present
study following treatment with NR-INF-02 may be attributed
to its possible anti-inflammatory effect.